A detailed history of Raymond James & Associates transactions in Icon PLC stock. As of the latest transaction made, Raymond James & Associates holds 169,496 shares of ICLR stock, worth $32.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
169,496
Previous 171,725 1.3%
Holding current value
$32.1 Million
Previous $53.8 Million 9.5%
% of portfolio
0.03%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$280.48 - $346.2 $625,189 - $771,679
-2,229 Reduced 1.3%
169,496 $48.7 Million
Q2 2024

Jul 19, 2024

BUY
$288.23 - $331.73 $2.58 Million - $2.96 Million
8,936 Added 5.49%
171,725 $53.8 Million
Q1 2024

Apr 22, 2024

SELL
$247.84 - $340.0 $959,636 - $1.32 Million
-3,872 Reduced 2.32%
162,789 $54.7 Million
Q4 2023

Jan 16, 2024

SELL
$222.83 - $285.76 $2.33 Million - $2.99 Million
-10,457 Reduced 5.9%
166,661 $47.2 Million
Q3 2023

Oct 24, 2023

SELL
$236.44 - $265.62 $7.27 Million - $8.17 Million
-30,759 Reduced 14.8%
177,118 $43.6 Million
Q2 2023

Jul 25, 2023

SELL
$183.12 - $250.2 $3.78 Million - $5.16 Million
-20,622 Reduced 9.02%
207,877 $52 Million
Q1 2023

Apr 14, 2023

SELL
$193.59 - $245.33 $2.34 Million - $2.96 Million
-12,085 Reduced 5.02%
228,499 $48.8 Million
Q4 2022

Feb 08, 2023

SELL
$173.9 - $224.8 $694,556 - $897,851
-3,994 Reduced 1.63%
240,584 $46.7 Million
Q3 2022

Oct 25, 2022

SELL
$183.25 - $247.5 $2.96 Million - $4 Million
-16,155 Reduced 6.2%
244,578 $44.9 Million
Q2 2022

Aug 12, 2022

BUY
$197.3 - $261.32 $1.03 Million - $1.37 Million
5,243 Added 2.05%
260,733 $56.5 Million
Q1 2022

May 11, 2022

BUY
$216.09 - $296.03 $4.09 Million - $5.6 Million
18,910 Added 7.99%
255,490 $62.1 Million
Q4 2021

Feb 08, 2022

BUY
$258.11 - $309.7 $3.04 Million - $3.65 Million
11,786 Added 5.24%
236,580 $73.3 Million
Q3 2021

Nov 02, 2021

BUY
$208.53 - $283.04 $15.6 Million - $21.2 Million
74,730 Added 49.8%
224,794 $58.9 Million
Q2 2021

Aug 11, 2021

BUY
$194.07 - $232.2 $6.87 Million - $8.22 Million
35,415 Added 30.89%
150,064 $31 Million
Q1 2021

May 14, 2021

BUY
$171.87 - $220.96 $5.48 Million - $7.05 Million
31,908 Added 38.56%
114,649 $22.5 Million
Q4 2020

Feb 12, 2021

SELL
$180.3 - $214.08 $482,843 - $573,306
-2,678 Reduced 3.14%
82,741 $16.1 Million
Q3 2020

Nov 04, 2020

BUY
$166.91 - $196.1 $801,668 - $941,868
4,803 Added 5.96%
85,419 $16.3 Million
Q2 2020

Jul 28, 2020

SELL
$129.79 - $170.94 $2.02 Million - $2.66 Million
-15,572 Reduced 16.19%
80,616 $13.6 Million
Q1 2020

Apr 21, 2020

SELL
$115.95 - $177.22 $1.18 Million - $1.81 Million
-10,218 Reduced 9.6%
96,188 $13.1 Million
Q4 2019

Feb 12, 2020

SELL
$139.48 - $172.23 $441,314 - $544,935
-3,164 Reduced 2.89%
106,406 $18.3 Million
Q3 2019

Nov 07, 2019

SELL
$146.89 - $161.41 $534,092 - $586,886
-3,636 Reduced 3.21%
109,570 $16.1 Million
Q2 2019

Aug 06, 2019

SELL
$129.99 - $153.97 $106,851 - $126,563
-822 Reduced 0.72%
113,206 $17.4 Million
Q1 2019

May 06, 2019

BUY
$121.3 - $146.95 $49,126 - $59,514
405 Added 0.36%
114,028 $15.6 Million
Q4 2018

Feb 11, 2019

SELL
$119.37 - $153.29 $1.19 Million - $1.53 Million
-9,957 Reduced 8.06%
113,623 $14.7 Million
Q3 2018

Nov 14, 2018

BUY
$131.3 - $153.75 $2.15 Million - $2.52 Million
16,411 Added 15.31%
123,580 $19 Million
Q2 2018

Aug 14, 2018

SELL
$111.38 - $137.03 $276,667 - $340,382
-2,484 Reduced 2.27%
107,169 $14.2 Million
Q1 2018

May 14, 2018

BUY
$103.82 - $123.9 $2.25 Million - $2.69 Million
21,694 Added 24.66%
109,653 $13 Million
Q4 2017

Feb 14, 2018

BUY
$111.14 - $123.05 $648,279 - $717,750
5,833 Added 7.1%
87,959 $9.87 Million
Q3 2017

Nov 13, 2017

BUY
$101.4 - $116.62 $946,974 - $1.09 Million
9,339 Added 12.83%
82,126 $9.35 Million
Q2 2017

Aug 14, 2017

BUY
N/A
72,787
72,787 $7.12 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $15.5B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.